Zacks Investment Research on MSN3h
Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know
Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...
Business Insider22d
Pacific Biosciences (PACB) Gets a Hold from Piper Sandler
In a report released today, David Westenberg from Piper Sandler reiterated a Hold rating on Pacific Biosciences (PACB – Research Report), with a price target of $2.00. The company’s shares ...
Bernstein Remains a Buy on Pacific Biosciences (PACB)
Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.